Phosphate and FGF-23

Kidney International

Volumn 79, Issue SUPPL. 121, 2011, Pages

  Jüppner, Harald ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

FGF 23; phosphate and calcium homeostasis; PTH

Indexed keywords

CALCITRIOL; CALCIUM; FIBROBLAST GROWTH FACTOR 23; KLOTHO PROTEIN; PARATHYROID HORMONE; PHOSPHATE; PHOSPHATE BINDING AGENT; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; OXYGENASE; SODIUM PHOSPHATE COTRANSPORTER 2A; SODIUM PHOSPHATE COTRANSPORTER 2C; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

CALCIUM HOMEOSTASIS; CHRONIC KIDNEY DISEASE; DISEASE COURSE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MORTALITY; NEPHRON; NONHUMAN; OSTEOBLAST; OSTEOCYTE; PARATHYROID HORMONE RELEASE; PHOSPHATE BLOOD LEVEL; PHOSPHATE EXCRETION; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; BONE DISEASE; CHRONIC KIDNEY DISEASE RELATED MINERAL AND BONE DISORDER; ENZYME ACTIVITY; KIDNEY DYSFUNCTION; PATHOPHYSIOLOGY; PREMATURE MORTALITY; PROTEIN FUNCTION; PSEUDOHYPOPARATHYROIDISM; VITAMIN BLOOD LEVEL;

EID: 79953272563     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.27     Document Type: Review

References (26)

1. Coloso RM, King K, Fletcher JW et al. Dietary P regulates phosphate transporter expression, phosphatase activity, and effluent P partitioning in trout culture. J Comp Physiol B 2003; 173: 519-530. (Pubitemid 37105691)
2. Dominguez JH, Gray RW, Lemann Jr J. Dietary phosphate deprivation in women and men: effects on mineral and acid balances, parathyroid hormone and the metabolism of 25-OH-vitamin D. J Clin Endocrinol Metab 1976; 43: 1056-1068.
3. Gattineni J, Bates C, Twombley K et al. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am J Physiol Renal Physiol 2009; 297: F282-F291.
4. Bergwitz C, Jüppner H. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med 2010; 61: 91-104.
5. Gutierrez O, Isakova T, Rhee E et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 2005; 16: 2205-2215. (Pubitemid 41716454)
6. Bricker NS. On the pathogenesis of the uremic state. An exposition of the 'trade-off hypothesis'. N Engl J Med 1972; 286: 1093-1099.
7. Jüppner H, Bastepe M. Different mutations within or upstream of the GNAS locus cause distinct forms of pseudohypoparathyroidism. J Pediatr Endocrinol Metab 2006; 19(Suppl 2): 641-646.
8. 3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am J Physiol Gastrointest Liver Physiol 2005; 289: G1036-G1042. (Pubitemid 41740608)
9. Farrow EG, Davis SI, Summers LJ et al. Initial FGF23-mediated signaling occurs in the distal convoluted tubule. J Am Soc Nephrol 2009; 20: 955-960.
10. Westerberg PA, Ljunggren O, Larsson TE et al. Fibroblast growth factor-23 and mineral metabolism after unilateral nephrectomy. Nephrol Dial Transplant 2010; 25: 4068-4071.
11. Hasegawa H, Nagano N, Urakawa I et al. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease. Kidney Int 2010; 78: 975-980.
12. Van Husen M, Fischer AK, Lehnhardt A et al. Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease. Kidney Int 2010; 78: 200-206.
13. Pereira RC, Juppner H, Azucena-Serrano CE et al. Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease. Bone 2009; 45: 1161-1168.
14. Fliser D, Kollerits B, Neyer U et al. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 2007; 18: 2600-2608.
15. Titan SM, Zatz R, Jorgetti V et al. FGF-23 as a predictor of renal outcome in diabetic nephropathy. (Renal week 2009 abstract F-PO1872). J Am Soc Nephrol 2009; 20: 540A.
16. Gutierrez OM, Januzzi JL, Isakova T et al. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 2009; 119: 2545-2552.
17. Nasrallah MM, El-Shehaby AR, Salem MM et al. Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients. Nephrol Dial Transplant 2010; 25: 2679-2685.
18. Perwad F, Azam N, Zhang MY et al. Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. Endocrinology 2005; 146: 5358-5364. (Pubitemid 41653049)
19. Burnett SM, Gunawardene SC, Bringhurst FR et al. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res 2006; 21:1187-1196. (Pubitemid 44128331)
20. Isakova T, Gutierrez OM, Wolf M. A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease. Kidney Int 2009; 76: 705-716.
21. Shimada T, Urakawa I, Isakova T et al. Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active. J Clin Endocrinol Metab 2010; 95: 578-585.
22. Heijboer AC, Levitus M, Vervloet MG et al. Determination of fibroblast growth factor 23. Ann Clin Biochem 2009; 46: 338-340.
23. Gutierrez OM, Mannstadt M, Isakova T et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008; 359: 584-592.
24. Jean G, Terrat JC, Vanel T et al. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. Nephrol Dial Transplant 2009; 24: 2792-2796.
25. Nagai S, Okazaki M, Segawa H et al. Acute down-regulation of sodium-dependent phosphate transporter NPT2a involves predominantly the cAMP/PKA pathway as revealed by signaling-selective parathyroid hormone analogs. J Biol Chem 2011; 286: 1618-1626.
26. Cancela AL, Oliveira RB, Graciolli FG et al. Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate. Nephron Clin Pract 2011; 117: c74-c82.